Access Bio: Atomo Diagnostics collaborates with Access Bio for rapid COVID-19 testing
Under the agreement, Access Bio is obliged to sell a minimum of two million Products by 30 September 2021
Read full article »
Access Bio researches, develops and manufactures in vitro diagnostic tests, bio-sensors and molecular diagnostic products.
Read more